Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R

World Journal of Gastroenterology

Volumn 21, Issue 10, 2015, Pages 2949-2958

  Gong, Yu ^a   Ren, Jun ^a   Liu, Kun ^a   Tang, Li Ming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Insulin like growth factor 1 receptor; miR 133a; Tumor suppressor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MICRORNA; MICRORNA 133A; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; IGF1R PROTEIN, HUMAN; MIRN133 MICRORNA, HUMAN; SOMATOMEDIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURGERY; CARCINOGENESIS; CARCINOGENICITY; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; COLONY FORMATION; CONTROLLED STUDY; DIFFERENTIATION; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA; WESTERN BLOTTING; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER STAGING; CELL DIFFERENTIATION; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TIME FACTOR; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTORS, SOMATOMEDIN; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TIME FACTORS; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84924943748     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i10.2949     Document Type: Article

References (27)

1. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005; 366: 1784-1793 [PMID: 16298215 DOI: 10.1016/S0140-6736(05)67725-2]
2. Varadhachary G, Ajani JA. Gastric cancer. Clin Adv Hematol Oncol 2005; 3: 118-124 [PMID: 16166979]
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
4. Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics 2010; 11: 537-561 [PMID: 21532838 DOI: 10.2174/138920210793175895]
5. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269 [PMID: 16557279 DOI: 10.1038/nrc1840]
6. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60 [PMID: 17894887 DOI: 10.1186/1476-4598-6-60]
7. Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010; 29: 5761-5771 [PMID: 20802530 DOI: 10.1038/onc.2010.352]
8. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L, Zhang WG, Nan KJ, Song TS, Huang C. MicroRNA profiling of human gastric cancer. Mol Med Rep 2009; 2: 963-970 [PMID: 21475928 DOI: 10.3892/mmr-00000199]
9. Guo J, Xia B, Meng F, Lou G. miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol 2014; 35: 1557-1564 [PMID: 24127040 DOI: 10.1007/s13277-013-1215-z]
10. Dong Y, Zhao J, Wu CW, Zhang L, Liu X, Kang W, Leung WW, Zhang N, Chan FK, Sung JJ, Ng SS, Yu J. Tumor suppressor functions of miR-133a in colorectal cancer. Mol Cancer Res 2013; 11: 1051-1060 [PMID: 23723074 DOI: 10.1158/1541-7786.MCR-13-0061]
11. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011; 104: 808-818 [PMID: 21304530 DOI: 10.1038/bjc.2011.23]
12. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883-891 [PMID: 20160723 DOI: 10.1038/sj.bjc.6605570]
13. Cui W, Zhang S, Shan C, Zhou L, Zhou Z. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. FEBS J 2013; 280: 3962-3974 [PMID: 23786162 DOI: 10.1111/febs.12398]
14. Kojima S, Chiyomaru T, Kawakami K, Yoshino H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M, Seki N. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 2012; 106: 405-413 [PMID: 22068816 DOI: 10.1038/bjc.2011.462]
15. Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, Zhu W, Shu Y, Liu P. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett 2014; 588: 1168-1177 [PMID: 24613927 DOI: 10.1016/j.febslet.2014.02.054]
16. Hartog H, Wesseling J, Boezen HM, van der Graaf WT. The insulin-like growth factor 1 receptor in cancer: old focus, new future. Eur J Cancer 2007; 43: 1895-1904 [PMID: 17624760 DOI: 10.1016/j.ejca.2007.05.021]
17. Othman N, Nagoor NH. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. Biomed Res Int 2014; 2014: 318030 [PMID: 24999473 DOI: 10.1155/2014/318030]
18. Xia H, Sun S, Wang B, Wang T, Liang C, Li G, Huang C, Qi D, Chu X. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. Int J Mol Sci 2014; 15: 11973-11983 [PMID: 25003638 DOI: 10.3390/ijms150711973]
19. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009; 24: 652-657 [PMID: 19175831 DOI: 10.1111/j.1440-1746.2008.05666.x]
20. Xu YJ, Fan Y. MiR-215/192 participates in gastric cancer progression. Clin Transl Oncol 2015; 17: 34-40 [PMID: 24981590 DOI: 10.1007/s12094-014-1194-6]
21. Tsai MM, Wang CS, Tsai CY, Chen CY, Chi HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY, Lin KH. MicroRNA- 196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett 2014; 351: 222-231 [PMID: 24933454 DOI: 10.1016/j.canlet.2014.06.004]
22. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, Ho MR, Tsai KW. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep 2012; 28: 1069-1076 [PMID: 22766685 DOI: 10.3892/or.2012.1899]
23. Cho WC. MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 2010; 1805: 209-217 [PMID: 19931352 DOI: 10.1016/j.bbcan.2009.11.003]
24. Ge J, Chen Z, Wu S, Chen J, Li X, Li J, Yin J, Chen Z. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer. Digestion 2009; 80: 148-158 [PMID: 19713703 DOI: 10.1159/000226089]
25. Murayama T, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J, Kawano T, Sugihara K. Relation between outcomes and localisation of p-mTOR expression in gastric cancer. Br J Cancer 2009; 100: 782-788 [PMID: 19223902 DOI: 10.1038/sj.bjc.6604915]
26. Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, Chen YW. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer 2014; 13: 6 [PMID: 24410957 DOI: 10.1186/1476-4598-13-6]
27. Qian X, Yu J, Yin Y, He J, Wang L, Li Q, Zhang LQ, Li CY, Shi ZM, Xu Q, Li W, Lai LH, Liu LZ, Jiang BH. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers. Cell Cycle 2013; 12: 1385-1394 [PMID: 23574723 DOI: 10.4161/cc.24477]